DFX Intelligence
Venture Capital Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Venture Capital Intelligence at $199 a month for every name. Every figure, date and source on this page is public either way.
Firms / E•••••• C•••••• L••
E•••••• C•••••• L••
Value-focused. Evidence-based. Business-building. We are E•••••• Health Capital, a late-stage venture capital and growth equity firm. E•••••• Health Capital, formerly known as Canepa Healthcare, specializes in medical devices, in vitro diagnostics, and disruptive digital health. We focus on private companies with commercialized products that need growth capital to achieve profitability. Learn More Our Team We are a…
venture manager, reported GAV $196M across 6 vehicles
Importance
26
moderate
Active deployment
33
moderate
Emerging
0
low
Completeness
75
high
Freshness
98
high
Research priority
12
low
Identity and regulatory footprint
- Headquarters
- Miami, FLadviserinfo.sec.gov
- Office address
- 777 BRICKELL AVE., SUITE 630, Miami, FL, 33131adviserinfo.sec.gov
- Business phone
- 212-913-9755adviserinfo.sec.gov
- Website
- e••••••.com
- SEC adviser type
- exempt reporting adviseradviserinfo.sec.gov
- SEC exemption claimed
- venture capital fund adviseradviserinfo.sec.govItem 2.B(1): advises solely venture capital funds
- Latest Form ADV
- Mar 20, 2026
- Private funds reported
- 2 (2 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets
- $215Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- Owners on Schedule A
- C•• P•••••••• S•• R••• (General Partner), F; A•••••••• J• S•••••• R•••••••• T•••• (Owner), E; C•• C•••••• S•• S•• R••• (Limted Partner), D; A•••• L•• (Owner), C; H••••••••• G••••• P•••••••• L•• (Owner), D; C••••• G••••• M•••••••• S•••• (Shareholder), E; C•• H••••••• L•••••• (Shareholder), E; B• C•••••• L•• (Owner), C
- business phone
- 212-913-9755adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
2 observed deals
Stated (the firm’s website)
- Sectors
- healthcare, medtech
- Stages
- growth
- Geography
- miami, new york
- Check size
- not stated; DFX does not estimate checks from round sizes
- Self-described
- growth investor
Observed (from deals on record)
Stage at participation
series d plus 100%
Stage at first entry
series d plus 100%
Sectors
unknown 50%Other Health Care 50%
lead rate 0%follow-on rate 0%new logos, 12 months 2
Funds and vehicles
6 reported
| Vehicle | Type | Vintage | Lifecycle | Reported GAV | Owners | Form D sold | Latest Form D |
|---|---|---|---|---|---|---|---|
| P•• 2••• F••••• F••• I•••• L•• | Feeder or parallel | 2024 form d first sale | Early deployment | unknown | unknown | $43.6M | Jan 7, 2025 |
| P•• 2••• F••••• F••• I•• L•• | Feeder or parallel | 2024 form d first sale | Early deployment | unknown | unknown | $2.6M | Jan 7, 2025 |
| P•• 2••• F••••• F••• I• L•• | Feeder or parallel | 2024 form d first sale | Early deployment | unknown | unknown | $6.6M | Jan 7, 2025 |
| P•• 2••• F••••• F••• I••••• L•• | Feeder or parallel | 2024 form d first sale | Early deployment | unknown | unknown | $5.6M | Jan 7, 2025 |
| E•••••• A••••••• H••••••••• F••• I•• L••• | Fund | 2023 adv first reported | Active deployment | $26.7M Aug 16, 2024 | 1 | unknown | unknown |
| C••••• A••••••• H••••••••• F•••• L••• | SPV or co-invest vehicle | unknown | Unknown | $169M Aug 16, 2024 | 3 | unknown | unknown |
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
5 current, 4 departed
A•••••••• S••••••
PartnerPartner
A•••••••• S••••••
PartnerManager/Partner · since Nov 1, 2014
P••• A••••• J•••• E•••••
PartnerOwner/Manager · since Nov 1, 2022
P••• E•••••
PartnerPartner
L•••• A••••
Platform and operationsChief Financial Officer
4 departed (kept with end dates)
- E•••• E•••• · Owner/Manager · Jan 1, 2010 to Mar 30, 2018 Inference
- E•••• E•••• · Shareholder · Dec 1, 2017 to May 22, 2024 Inference
- F•••••••• F•••• R•••••••• · Shareholder · Aug 1, 2013 to May 22, 2024 Inference
- K••• E••••••••• · Shareholder · Jul 1, 2023 to May 22, 2024 Inference
Investments on record
2 edges, 2 companies, 0 partner-attributed
| Company | Round | Role | Partner | Round size | This investor | Date | Source |
|---|---|---|---|---|---|---|---|
| C•••••• | portfolio listing | unknown | unknown | unknown | unknown | Sep 16, 2026 | Fact Venture organization websites (about, team, portfolio, thesis, news pages) |
| G• M•••••• T••••••••• I••• | Series E · Series D+ | participant | unknown | $100M | unknown | Jun 9, 2026 | Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS) |
“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.
Co-investors
5 relationships from shared deals, counted for the whole firm
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
9 dated events
- May 22, 2024F•••••••• F•••• R•••••••• (Shareholder) no longer on Schedule A of E•••••• C•••••• L••
- May 22, 2024E•••• (nmn) E•••• (Shareholder) no longer on Schedule A of E•••••• C•••••• L••
- May 22, 2024K••• (nmn) E••••••••• (Shareholder) no longer on Schedule A of E•••••• C•••••• L••
- Mar 31, 2023E•••••• A••••••• H••••••••• F••• I•• L••• first reported on Form ADV by E•••••• C•••••• L•• (Venture Capital Fund), GAV $10,271,217Fund first reported on Form ADVFundsFactE•••••• A••••••• H••••••••• F••• I•• L•••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Dec 1, 2017E•••• E (mi Only) E•••• joined Schedule A of C••••• H•••••••••, LLC as Shareholder
- Apr 18, 2017C••••• H•••••••••, LLC first filed Form ADV (ERA)First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Apr 18, 2017C••••• A••••••• H••••••••• F•••• L••• first reported on Form ADV by C••••• H•••••••••, LLC (Other Private Fund), GAV $116,144,861Fund first reported on Form ADVFundsFactC••••• A••••••• H••••••••• F•••• L•••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Jan 1, 2014K••• E••••••••• joined Schedule A of C••••• H•••••••••, LLC as Shareholder
- Aug 1, 2013F•••••••• F•••• R•••••••• joined Schedule A of C••••• H•••••••••, LLC as Shareholder
Classification history
- Sep 12, 2026Institutional venture firm (confirmed, 95%, cls-1)venture manager, reported GAV $196M across 6 vehicles
- Sep 12, 2026Institutional venture firm (confirmed, 95%, cls-1)venture manager, reported GAV $196M across 2 vehicles
Evidence
55 observations from 3 sources